63 patents
Utility
Clinical decision support system and methods
5 Dec 23
The present invention provides clinical decision support that can be used with non-portable and portable systems when delivering and/or monitoring delivery of a therapeutic gas comprising nitric oxide to a patient.
Jaron Acker, Craig R. Tolmie
Filed: 7 Nov 19
Utility
Use and monitoring of inhaled nitric oxide with left ventricular assist devices
19 Sep 23
Described are systems and methods for administration of nitric oxide (NO) with use of left ventricular assists devices (LVADs), as well as systems and methods for monitoring the NO delivery devices and/or the LVAD.
Jim Potenziano, Douglas Alan Greene, Craig Flanagan
Filed: 25 Jun 21
Utility
Methods of modulating pericytes
12 Sep 23
The present disclosure is directed to methods of modulating pericytes in subjects in need thereof.
Dale Wright
Filed: 25 Feb 21
Utility
Apparatus and method for detecting liquid level in a clear or partially clear container
5 Sep 23
A trap bowl is provided to accumulate liquid droplets from a filter, as a liquid content.
Scott I. Biba
Filed: 15 Dec 22
Utility
Systems and method for delivery of therapeutic gas to patients, in need thereof, receiving breathing gas from a ventilator that varies at least pressure and/or flow using enhanced therapeutic gas (NO) flow measurement
11 Apr 23
Provided herein are systems and methods for delivery of therapeutic gas to patients, in need thereof, by receiving breathing gas from a high frequency ventilator using at least enhanced therapeutic gas (e.g., nitric oxide, NO, etc.) flow measurement.
Jaron M. Acker, Craig R. Tolmie
Filed: 23 Oct 20
Utility
Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
4 Apr 23
The present disclosure provides pharmaceutical compositions that provide immediate release of active ingredients and have abuse deterrent properties.
Alex Micka, Kai Feng, Tsz Chung Lai, Jonathan Gaik
Filed: 1 Jul 15
Utility
Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
21 Feb 23
The present disclosure provides pharmaceutical compositions that provide immediate release of active ingredients and have abuse deterrent properties.
Alex Micka, Kai Feng, Tsz Chung Lai, Jonathan Gaik
Filed: 11 Aug 20
Utility
Apparatus and method for detecting liquid level in a clear or partially clear container
17 Jan 23
A trap bowl is provided to accumulate liquid droplets from a filter, as a liquid content.
Scott I. Biba
Filed: 23 Dec 19
Utility
Systems and methods for manufacturing and safety of an NO
17 Jan 23
The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy.
Jaron M. Acker, Thomas Kohlmann
Filed: 3 Jul 19
Utility
Systems and methods for delivery of therapeutic gas
20 Dec 22
Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient.
Jaron M. Acker, Jeff Milsap, Robin Roehl, Jeffrey Schmidt, Craig R. Tolmie
Filed: 21 Jan 20
Utility
Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
6 Dec 22
The present disclosure provides pharmaceutical compositions that provide immediate release of active ingredients and have abuse deterrent properties.
Alex Micka, Kai Feng, Tsz Chung Lai, Jonathan Gaik
Filed: 7 Jun 18
Utility
Abuse deterrent immediate release capsule dosage forms
25 Oct 22
Capsule dosage forms that provide immediate release of active ingredients and have abuse deterrent properties.
Tsz Chung Lai, Rebecca Sue Walker, Chirag Patel, Jaehan Park
Filed: 18 Sep 19
Utility
Systems and method for delivery of therapeutic gas to patients in need thereof using enhanced breathing circuit gas (BCG) flow measurement
18 Oct 22
The present invention generally relates to systems and method for delivery of therapeutic gas to patients in need thereof using enhanced breathing circuit gas (BCG) flow measurement.
Jaron M. Acker, Craig R. Tolmie
Filed: 22 Jan 19
Utility
Method of identifying and treating premature infants at risk for BPD
18 Oct 22
Methods for identifying premature infants at risk for developing bronchopulmonary dysplasia and/or most likely to benefit from administration of inhaled nitric oxide for prevention of bronchopulmonary dysplasia (BPD).
Douglas Stuart Greene, Joseph J. Medicis, Jim Potenziano
Filed: 27 Feb 20
Utility
Spray dried compositions having different dissolution profiles and processes for their preparation
11 Oct 22
The present disclosure provides compositions having different dissolution profiles.
Joseph M. Davis, Robert C. Cuca, Edward J. Beasley
Filed: 27 May 15
Utility
Apparatus and method for humidity conditioning sample gas of a patient breathing circuit affiliated with a ventilator and/or nitric oxide delivery system
27 Sep 22
A therapeutic gas is administered to a patient.
John P. Stanton, John V. Berndt
Filed: 28 Oct 19
Utility
Extended release, abuse deterrent dosage forms
20 Sep 22
Extended release, abuse deterrent dosage forms comprising crush-resistant controlled-release particles that provide abuse deterrent properties to the dosage forms.
Jonathan Gaik, Jaehan Park, Ryan Lathrop, Gary Nichols, John Schallom
Filed: 13 Mar 20
Utility
Administration and monitoring of nitric oxide in ex vivo fluids
16 Aug 22
Described are systems and methods for monitoring administration of nitric oxide (NO) to ex vivo fluids.
Jim Potenziano, Douglas R. Hansell, Jeff Griebel, Eddie Costa, Lisa Cooper, David William Newman
Filed: 23 Apr 20
Utility
Systems and methods for indicating lifetime of an NO
10 May 22
The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy.
Jaron Acker, Muhammad Asif, Craig Flanagan, Douglas Alan Greene, Sarah Jayne Ridley, Frank Kenneth Schweighardt, Lien-Lung Sheu
Filed: 26 Nov 19
Utility
Administration and monitoring of nitric oxide in ex vivo fluids
5 Apr 22
Described are systems and methods for monitoring administration of nitric oxide (NO) to ex vivo fluids.
Jim Potenziano, Douglas R. Hansell, Jeff Griebel, Eddie Costa, Lisa Cooper, David William Newman
Filed: 21 Apr 17